Merck & Co., Inc. – LSE:0QAH.L
Merck & Co. stock price today
Merck & Co. key metrics
Market Cap | 285.50B |
Enterprise value | 275.74B |
P/E | 20.78 |
EV/Sales | 4.36 |
EV/EBITDA | 14.38 |
Price/Sales | 3.98 |
Price/Book | 5.67 |
PEG ratio | -1.70 |
EPS | 0.91 |
Revenue | 61.43B |
EBITDA | 8.71B |
Income | 2.30B |
Revenue Q/Q | 9.12% |
Revenue Y/Y | 6.16% |
Profit margin | 19.22% |
Oper. margin | 23.52% |
Gross margin | 74.97% |
EBIT margin | 23.52% |
EBITDA margin | 14.19% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMerck & Co. stock price history
Merck & Co. stock forecast
Merck & Co. financial statements
| Jun 2023 | 15.03B | -5.97B | -39.74% |
|---|---|---|---|
| Sep 2023 | 15.96B | 4.74B | 29.73% |
| Dec 2023 | 14.63B | -1.22B | -8.38% |
| Mar 2024 | 15.80B | 4.76B | 30.12% |
| Payout ratio | 63.72% |
|---|
| 2019 | 2.56% |
|---|---|
| 2020 | 3.15% |
| 2021 | 3.41% |
| 2022 | 2.5% |
| 2023 | 2.62% |
| Jun 2023 | 104469000000 | 65.72B | 62.92% |
|---|---|---|---|
| Sep 2023 | 106727000000 | 65.42B | 61.3% |
| Dec 2023 | 106675000000 | 69.04B | 64.72% |
| Mar 2024 | 105849000000 | 65.42B | 61.81% |
| Jun 2023 | 3.70B | -11.44B | 3.75B |
|---|---|---|---|
| Sep 2023 | 7.71B | -334M | -4.26B |
| Dec 2023 | 246M | 53M | -2.24B |
| Mar 2024 | 3.09B | -1.37B | -2.81B |
Merck & Co. alternative data
| Aug 2023 | 67,000 |
|---|---|
| Sep 2023 | 67,000 |
| Oct 2023 | 67,000 |
| Nov 2023 | 67,000 |
| Dec 2023 | 67,000 |
| Jan 2024 | 67,000 |
| Feb 2024 | 67,000 |
| Mar 2024 | 70,000 |
| Apr 2024 | 70,000 |
| May 2024 | 70,000 |
| Jun 2024 | 70,000 |
| Jul 2024 | 70,000 |
Merck & Co. other data
-
What's the price of Merck & Co. stock today?
One share of Merck & Co. stock can currently be purchased for approximately $89.7.
-
When is Merck & Co.'s next earnings date?
Unfortunately, Merck & Co.'s (0QAH.L) next earnings date is currently unknown.
-
Does Merck & Co. pay dividends?
Yes, Merck & Co. pays dividends and its trailing 12-month yield is 3.13% with 64% payout ratio. The last Merck & Co. stock dividend of undefined was paid on 3 Sep 2025.
-
How much money does Merck & Co. make?
Merck & Co. has a market capitalization of 285.50B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1.4% to 60.12B US dollars.
-
What is Merck & Co.'s stock symbol?
Merck & Co., Inc. is traded on the LSE under the ticker symbol "0QAH.L".
-
What is Merck & Co.'s primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - General industry.
-
How do i buy shares of Merck & Co.?
Shares of Merck & Co. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Merck & Co. have?
As Jul 2024, Merck & Co. employs 70,000 workers.
-
When Merck & Co. went public?
Merck & Co., Inc. is publicly traded company for more then 19 years since IPO on 6 Mar 2006.
-
What is Merck & Co.'s official website?
The official website for Merck & Co. is merck.com.
-
Where are Merck & Co.'s headquarters?
Merck & Co. is headquartered at 2000 Galloping Hill Road, Kenilworth, NJ.
-
How can i contact Merck & Co.?
Merck & Co.'s mailing address is 2000 Galloping Hill Road, Kenilworth, NJ and company can be reached via phone at +90 87404000.
Merck & Co. company profile:
Merck & Co., Inc.
merck.comLSE
70,000
Drug Manufacturers - General
Healthcare
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Kenilworth, NJ 07033
:
:
:
